<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-72XAJHQK</identifier><date>2022</date><creator>Korpar, Marjetka</creator><relation>documents/doc/7/URN_NBN_SI_doc-72XAJHQK_001.pdf</relation><relation>documents/doc/7/URN_NBN_SI_doc-72XAJHQK_001.txt</relation><format format_type="issue">2</format><format format_type="volume">73</format><format format_type="type">article</format><format format_type="extent">str. 164-171</format><identifier identifier_type="COBISSID_HOST">142179331</identifier><identifier identifier_type="ISSN">2536-4316</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-72XAJHQK</identifier><language>slv</language><publisher publisher_location="Ljubljana">Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">agonisti receptorjev</subject><subject language_type_id="eng">clinical case</subject><subject language_type_id="eng">diabetes</subject><subject language_type_id="slv">farmacevt</subject><subject language_type_id="slv">GLP-1</subject><subject language_type_id="eng">insulin</subject><subject language_type_id="slv">inzulin</subject><subject language_type_id="slv">klinični primer</subject><subject language_type_id="eng">pharmacist</subject><subject language_type_id="eng">receptor agonists</subject><subject language_type_id="slv">sladkorna bolezen</subject><title>Subcutaneous drugs for the treatment of diabetes – clinical cases of a pharmacist</title><title>Zdravila za subkutano aplikacijo za zdravljenje sladkorne bolezni – klinični primeri farmacevta</title></Record>